Prevalence and risk factors for nausea and vomiting in breast cancer patients undergoing chemotherapy.
What's New
Nearly half of breast cancer patients undergoing chemotherapy experienced chemotherapy-induced nausea and vomiting, with younger age and motion sickness history identified as key risk factors.
Detailed Summary
A meta-analysis of 12 studies found the overall prevalence of chemotherapy-induced nausea and vomiting (CINV) in breast cancer patients was 48%. Multivariate analysis identified age ≤45 years (OR 2.36), history of motion sickness (OR 2.05), and ≥3 chemotherapy cycles (OR 2.27) as independently associated risk factors, while anxiety and comorbidities were not significantly associated.
Study Population
Breast cancer patients undergoing chemotherapy, primarily from Asian populations (12 studies)
This research is for informational purposes only — discuss with your doctor before making any changes to your care.
Rivvet may earn a referral fee if you book through this link.
Discussion
Loading comments...
Comments are public. Be respectful and remember: this is not medical advice. Do not share personal health information.